rs4775919

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000559909.1(MIR4713HG):​n.194+116031G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.833 in 152,044 control chromosomes in the GnomAD database, including 53,013 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.83 ( 53013 hom., cov: 30)

Consequence

MIR4713HG
ENST00000559909.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0990

Publications

1 publications found
Variant links:
Genes affected
MIR4713HG (HGNC:53124): (MIR4713 host gene)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000559909.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.96 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000559909.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MIR4713HG
NR_146310.1
n.194+116031G>A
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MIR4713HG
ENST00000559909.1
TSL:4
n.194+116031G>A
intron
N/A
MIR4713HG
ENST00000805692.1
n.278+116031G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.833
AC:
126568
AN:
151926
Hom.:
52956
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.814
Gnomad AMI
AF:
0.865
Gnomad AMR
AF:
0.747
Gnomad ASJ
AF:
0.816
Gnomad EAS
AF:
0.983
Gnomad SAS
AF:
0.815
Gnomad FIN
AF:
0.885
Gnomad MID
AF:
0.839
Gnomad NFE
AF:
0.846
Gnomad OTH
AF:
0.817
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.833
AC:
126688
AN:
152044
Hom.:
53013
Cov.:
30
AF XY:
0.833
AC XY:
61939
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.815
AC:
33762
AN:
41434
American (AMR)
AF:
0.747
AC:
11406
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.816
AC:
2831
AN:
3470
East Asian (EAS)
AF:
0.983
AC:
5090
AN:
5180
South Asian (SAS)
AF:
0.816
AC:
3927
AN:
4814
European-Finnish (FIN)
AF:
0.885
AC:
9371
AN:
10584
Middle Eastern (MID)
AF:
0.840
AC:
247
AN:
294
European-Non Finnish (NFE)
AF:
0.846
AC:
57542
AN:
67986
Other (OTH)
AF:
0.819
AC:
1723
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1047
2094
3141
4188
5235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.838
Hom.:
26992
Bravo
AF:
0.821
Asia WGS
AF:
0.902
AC:
3139
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.0
DANN
Benign
0.36
PhyloP100
-0.099

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4775919;
hg19: chr15-51445909;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.